ScholarLens Back to search
2007•European Journal of Cancer SupplementsRequires access

395 POSTER Quantitative prediction of cancer drug efficacy by AKT and ERK1/2 down regulation in pancreatic cancer

Jun Shibata, Taro Masaki, Toshihiro Ona

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ku70, Ku80, DNA ligase, Non-homologous end joining, DNA repair protein XRCC4, Genome instability, DNA repair, Biology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
395 POSTER Quantitative prediction of cancer drug efficacy by AKT and ERK1/2 down regulation in pancreatic cancer — Research Paper | ScholarLens